Novo Nordisk to Resubmit Wegovy Heart Failure Application with Updated Clinical Data
Denmark’s pharmaceutical giant, Novo Nordisk (NYSE: NVO), has reported significant findings on the efficacy of...
September 2024
AccurEdit Therapeutics’ Gene-Editing Drug ART001 Clears FDA Hurdle for US Clinical Trials
SUZHOU—AccurEdit Therapeutics (Suzhou) Co., Ltd, a leading Chinese specialist in gene editing therapies, has announced...
Hybio Pharmaceutical Inks Licensing Deal with Mullan Pharmaceutical for Liraglutide Biosimilar
BEIJING—Hybio Pharmaceutical Co., Ltd (SHE: 300199), a Chinese biopharmaceutical company, has entered into a licensing...
Allist Pharmaceuticals Acquires Jacobio’s G12C Inhibitor and SHP2 Inhibitor Rights for Greater China Region
SHANGHAI—Allist Pharmaceuticals Co., Ltd, a Shanghai-based biotech company, has entered into a licensing agreement with...
Baheal Pharmaceutical Group to Establish R&D Center for Myocardial Repair with CAMS Fuwai Hospital
BEIJING—Baheal Pharmaceutical Group, a leading healthcare services and distribution company in China, is venturing into...
Bio-Thera Solutions’ BAT2406 Biosimilar Gets Green Light for Clinical Trials in China
GUANGZHOU—Bio-Thera Solutions (SHA: 688177), a leading biopharmaceutical company based in Guangzhou, has received approval from...
NMPA Unveils 82nd Batch of Reference Drugs for Generic Quality Evaluation
The National Medical Products Administration (NMPA) has announced the release of the 82nd batch of...
Hainan Province Unveils Ambitious Three-Year Plan for Digital Health Innovation and Economy Expansion
HAIKOU—The People’s Government of Hainan Province has unveiled the “Hainan Province’s Three Year Action Plan...
China Expands Medical Insurance Coverage to Include Assisted Reproductive Technology in 19 Regions
BEIJING—As of September 1, 2024, a total of 19 provinces, municipalities, and the Xinjiang Production...
BioAge Labs Taps Former GSK CEO Jean-Pierre Garnier as Chairman
NEW YORK—BioAge Labs, a US-based biotechnology company specializing in anti-aging therapies, has announced the appointment...
China’s NMPA Suspends Dr. Reddy’s Atomoxetine Imports Amid Quality Concerns
BEIJING—The National Medical Products Administration (NMPA) has issued a notification to immediately suspend the import,...
Roche Diagnostics to Double Down on China with RMB 3 Billion Suzhou Plant Expansion
SUZHOU—Roche Diagnostics, the Swiss healthcare giant, has entered into a new investment agreement with the...
WuXi Biologics to Acquire Full Control of Vaccine Contract Services Subsidiary for $108.5 Million
HONG KONG—WuXi Biologics (HKG: 2269), a leading global open biopharmaceutical technology platform company, has announced...
Tiantan Biological to Acquire Wuhan Zhongyuan Ruide for $185 Million, Expanding Plasma Resources
BEIJING—Beijing Tiantan Biological Products Co., Ltd (Tiantan Biological, SHA: 600161) has announced that its subsidiary,...
Junshi Biosciences Logs 17.37% Revenue Growth in 2024H1, Fueled by Loqtorzi Sales Surge
SHANGHAI—Shanghai Junshi Biosciences Co., Ltd (HKG: 1877; SHA: 688180) has announced its financial results for...
MicroPort Medical Reports 17% Revenue Growth in 2024H1, Driven by Subsidiaries’ Performance
HONG KONG—MicroPort Medical Science and Technology Co., Ltd (HKG: 0853), a leading medical device company,...
Sino Medical Sciences Secures Hong Kong Approval for Coronary Balloon Dilation Catheter
HONG KONG—Sino Medical Sciences Technology Inc., (SHA: 688108), a leading medical device company based in...